Zepbound, Semaglutide, and Wegovy all serve similar functions in chronic weight management, with Semaglutide being the active ingredient in Wegovy, differentiating it from Zepbound
Phase III, PIONEER Program Multiple phase III efficacy trials have been fully published and/or presented in abstract form
Improvements were also reported across cardiovascular risk markers including non-HDL cholesterol, triglycerides, and systolic blood pressure
A patent that expires early after an extension provides less value than a later-expiring patent with a shorter extension, even if both technically qualify
The transformed Pichia pastoris cells are induced to express these proteins by adding 0.5% methanol daily to the culture, respectively